← Back
$LBRX All transactions

LB PHARMACEUTICALS INC

D

$ Value

Shares

1,255

Price

Filed

Sep 12

Insider

Name

PRENSKY ZACHARY

Title

CIK

0001167585

Roles

Director

Transaction Details

Transaction Date

2025-09-10

Code

D

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

Footnotes

Immediately exercisable. | The transactions reported herein reflect a one-time stock option repricing, effective on September 10, 2025, which reduced the per share exercise price of each repriced option to $15, representing the initial public offering price of the Issuer's common stock (the "Option Repricing"). Except as modified by the Option Repricing, all other terms and conditions of the repriced options, including, without limitation, any provisions with respect to vesting, remain in full force and effect. | One fourth (1/4) of the shares subject to the option award vested on August 25, 2024 and the remaining shares subject to the option vested or shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date. | One fourth (1/4) of the shares subject to the option award vested on June 28, 2025 and the remaining shares subject to the option vested or shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date. | The option award shall vest in three (3) equal annual installments on September 10, 2026, September 10, 2027 and September 10, 2028, subject to the Reporting Person's continuous service through such vesting date.

Filing Info

Accession No.

0001415889-25-024448

Form Type

4

Issuer CIK

0001691082

PRENSKY ZACHARY's History

Date Ticker Type Value
2025-09-10 LBRX D
2025-09-10 LBRX A
2025-09-10 LBRX D
2025-09-10 LBRX A
2025-09-10 LBRX D
2025-09-10 LBRX A
2025-09-10 LBRX D
2025-09-10 LBRX A
2025-09-10 LBRX D
2025-09-10 LBRX A

Other Insiders at LBRX (90d)

Insider Bought Sold Last
Deep Track Biotechnology Master Fund, Ltd. $10.0M 2026-02-06
Lenz Robert A. 2026-03-06